Patient-Centricity – a Winning Formula
There has been considerable discussion around the concept of patientcentricity in the pharmaceutical community. The industry has taken a collective…
There has been considerable discussion around the concept of patientcentricity in the pharmaceutical community. The industry has taken a collective…
Where information overload has started to slow innovation and efficiency in medicinal markets, could artificial intelligence and machine learning help…
The healthcare industry needs a fully connected IT infrastructure, integrating information from multiple systems to ease administrative workloads, facilitate patient-provider…
Pharmaceutical companies have been working for years on leveraging their clinical research data in more efficient ways, but other sectors…
In this paper, Chris Hamilton, Chief Commercial Officer at CROS NT, analyses how it is important to delve into the…
In this paper, Laure Lam Hung PhD, Project Manager and Clinical Research Associate at CIDP and Dr Tarkeswarnath Bachoo MBBS,…
The US Food and Drug Administration (FDA) allows for some flexibility related to changes in clinical trial protocols—for example, with…
Immunostimulating interstitial laser thermotherapy (imILT) is a treatment protocol for solid tumours developed to destroy the tumour at the treatment…
In industry-sponsored clinical trials, as the sponsors are for-profit companies, contract negotiations with the trial sites can be difficult and…
More than six years have passed since the federal law ‘On Circulation of Medicines’ came into effect, replacing the law…